Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree but instead of AMC see Celator. $1.36 to $39
Well if approval for NWBO is announced by surprise before any PDUFA date is announced that would be a 100 megaton explosion in share price. Given what shortsellers have done to NWBO over the years and by extension cancer patients LP would be righteous to exact that amount of revenge. FDA approval then TLD with Journal to educate Oncologists for Rx.
Does your post stand for the proposition that NWBO may have already filed for approval with the FDA? And then the plan would be to release TLD and Journal Publication after approval? I can not see that as a possibility because the FDA publish the PDUFA dates.
Also how can NWBO be less than 6 month's from approval when no PDUFA date has been published? (Regarding the Coming Soon Ad on tote bag speculation)
Yes Sir! That is exactly the way I read it as well. Approval is extremely likely and Management is attempting to make the process as fool proof as possible. Hence the extra careful handling of TLD announcement.
True this! Thanks for the injection of reasonableness. The tote bag IMO is just a tote bag. Not a 6 month's from approval announcement or prediction.
The bag meant one thing. It meant that NWBO was a sponsor of SNO and therefore implied that while NWBO is not presenting at SNO, NWBO is alive and still in the Game.
There are no circuit breakers on the OTC. I hope people realize that and therefore tefrain from setting stop loss orders that are visible on level 3 where the MM see all open orders. If one must set such orders set limit stop where not visible to anyone except your own broker. But beware your brokers employees may trade against you then. But at least it is not visible to anyone on level 3.
Glad that a NWBO naysayer is a Relief Therapudics believer. Maybe you got it backwards? Sorry to NWBO believers who are also into Relief. Just my opinion.
Gilead acquired Imunomedics for $21 Billion. A much more narrow and limited.potential company.( IMo) I am not making market cap predictions either, the M&A market does.
Thus $10-30 Billion. All the talk of wow I will sell at $5 is BS brainwashing.
Yes.Amusing to watch posters set up a Straw Man emblazoned with NWBO in the form of SNO presentation then blow it up with an M-80 firecracker while in the distance there is a slow moving armoured column flying the flags of Dr Liu and UCLA barely kicking up dust and not out running the regulatory process, those filings and the financing. There is no fast moving Calvary to alert or cause concerns to those that oppose NWBO. Not looking for a Calvary or Ex-Machina. NWBO will not need that. No partnership or buyout will be needed.
No surprises. Just methodical advance towards the goal of approval and manufacturing capacity advancing on similar timelines. Watch for TLD close on heels of the manufacturing facility approval.
Initial market cap $10-30 billion on uplist to Nasdaq.
The shortest distance to a target is a straight line. But without a straight line to a target then ballistic calculations are required. This becomes problematic with a moving target. NWBO needs to hit the target. That is more important than taking a quick shot.
Agreed. NWBO advancement is to important to risk when no clear line of site on the regulatory target as the regulatory guidance is in flux and a new FDA commissioner has been proposed. Why risk a premature shot on goal when NWBO has methodically marched forward for so many years.
Trusting that the loan was a stop gap measure, but wondering why the financing whether by loan or stock sale was undertaken so late. Something, whether a timeline or financing prospects might have slipped. Maybe it is too much to expect for a pre-revenue biotech to take a low risk approach to regulatory approval and a low risk approach to financing as well.
So true. However, what are the undisputed facts? The unblinded data?
If that data is true what does logic devoid of emotion reach as a conclusion?
A glitch or ghost in the machine?
That would be contrived. Mathmatics and computer circuits give conclusions not opinions.
The logic of your prior post was too obvious therefore will do nothing to enlighten those that are oblivious. Logical arguments are not opinions they are conclusions and if based on irrefutable facts the conclusions themselves are irrefutable.
That said I doubled UP on my modest position. This might be the best opportunity to accumulate before the next positive catalyst as I can not foresee further developments which would be perceived as negative. I actually think the loan while not on the best terms and increased the cost of the prior loan as positive because OTLK now has the capital to complete the BLA.
Filing of the BLA is expensive. But now they have the cash. I would have preferred that they sell stock instead. They will need to get the BLA right the first time because if not accepted OTLK will be in serious financial difficulty.
Amerex appears to have been more than incompetent but rather double agent saboteurs. Given the disruptive nature of Leronliimab it stands to reason those that bribe the FDA would at least be tempted to bribe Amerex.
Victim impact is irrelevant in Federal mandatory sentencing crimes. If there is a charge to be made against Nader it does not have to center on a conspiracy or involve conspirators at all. An indictment of Sykes or Left will subject everyone that was involved in the conspiracy down to the small time trader to the same mandatory sentencing under Federal Statutes same prison sentences as the kingpins. Victim impact statements are irrelevant to these statutes conviction under these statute and under any crime anywhere in the USA. Olny in sentencing under Court discretion. They do not build cases on victim impact as it is irrelevant as an element of the crime. Nadermaybe under investigation but it is strange that he has not been indicted yet as everything is out in the open and recently the S3 was deemed effective in just the last few weeks by the SEC. This mitigates against even SEC violations. However if the FBI is now showing up to question traded of the stock not insiders it indicted Nader was cleared and the Investigation is proceeding against active traders of CYDY that also traded CYDY stock especially mid 2020. Karma is a bitch but the FBI is a bigger problem for Manipulators like Left and Sykes and their followers as well it seems.
According to the posters it is not random shareholders it is active traders of CYDY stock that also actively post regarding CYDY in social media. Those posters believe that the questions regarding their trading of CYDY stock is related to an investigation of Nader. However the trading of stock by these individuals could not be relevant to an investigation of Nader. If what they say is true it means the investigation is about the trading of stock by those outside the company not Nader.
I am hearing on Reddit that individual shareholders are being visited by the FBI and questioned about their trading in CYDY stock. Not subpoenas mind you unannounced visits like one might think how suspects are questioned.
Is the DOJ investigation about Nader or about Skyes and Left for the collusive and coordinated trading both long and short to profit off of social media lies of Left and the Leronsaline guy with the garbage bag stock blog.
It is an error at TDA. Mine is showing some other misquoted stocks as well.
Yes and Northwest.
Anyone holding stocks of the majority of the market in the coming 2008 style crash coming as a result of a fresh wave of financial crisis triggered as 2008 by spiking gasoline prices as oil hits $100-200 bbl and gasoline spikes to $4 plus where one chooses between keeping ones job by spending the mortgage payment on gasoline instead same as the 2008 trigger. I remember.
One can not measure or predict the magnitude only that is is coming soon.
CYDY could be surging higher as the overall market crashes.
Maybe a point there but is misses the primary point. FDA has some appearances of suppression all preventative measures the are not vaccines. Ivermectin is likely a preventative same as Querctin and zinc. HCQ and zinc.
The actions of FDA or inactions is more likely due to its non-role in regulation of supplements rather than a conspiracy and corruption.
The boogie man if there is a bureaucratic boggieman is likely as relates to Invermectin to be someone with a lot of political muscle in the NIH and CDC. Not just Fauci but operatives of the Administration. Cabinet level decisions.
Cabinet level decisions are the easiest to influence with public support as they stand for elections, they are also the easier to corrupt. BP corrupts Cabinet level decisions more than FDA by political donations. Therefore the only natural checks and balance to these donations is wide spread voter support.
The Philippines and Brazil might show significant utility of Leronlimab to gain support of the US population it pressure the Administration for therapudics like Leronlimab and preventatives like Ivermectin somewhere around six months before the US Mid Term Elections.
By that time it should be evident to all regarding the short fall of the three shots of mRNA vaccines. The random variables of natural course mutations of the virus can not be accurately predicted or quantified.
Leonlimab is the precious life saver and will likely be rationed. Ivermectin can be produced easily and cheaply and might alter the course of this pandemic for prevention as it has shown in a Province of India where the incidence of Covid was decreased drastically in absence of vaccination compared to Karala Province India where vaccination rates were the highest but still have much worse Covid. Same in Isreal and other high vaccination populations.
Novavax Covid vaccine should also bear watching.
Check SEC filings. The SEC filed notice of Effectiveness a few days ago. SMH.
Yes! Cut to the Chase!:
New authorized shares of 200 million with SEC notice of effectiveness currently. All finance options for stock sales and related
Anyone that does not believe that NWBO is a possible, probable 30x bagger from here is in danger of missing out by selling at a 5x or 10x level and missing the greater magnitude to the revalueing of NWBO after TLD.
Remarkably, this post is an apropos cut on form that draws its parallel to holding NWBO stock long term with learning to wind surf. To learn to Wind Surf one must by necessity and convention control the chute while being pulled through the water before one advances to riding on the board on the surface of the sea powered by the chute and the Wind.
The market is the Wind the Chute is management the Wind Surf board is the clinical trials and the Sea is acceptance by the scientific community together with Doctors, Insurance and Government claim coverage.
the last beaten down paradigm shifting stock I bought at $1.26 blossomed to $30 plus within eighteen months. This was prior any Phase 3 readout in any indication. NWBO seems to be approaching a steep revaluation parabola. I think the retail shareholders of NWBO differ from most retail in other biotech as they understand the long term prospects of NWBO and may not be willing to cash out with a 10x gain but chose instead to own their shares of NWBO for much larger gains than than
Just 10x from here.
Where else could one find a possible 30x bagger in less than 18 months on that kind of scale?
The recent M&A in the oncology space illustrates that NWBO can reach $30 billion market cap with current share structure. This would be 30x current share price with no reverse split.
Agreed. Well stated.
Agreed. I apprieciate all your posts on the more esoteric propositions. I am happy to read only and reserve comments for the most ridiculous short propositions that seem reasonable on the face. Sure it is theoretically possible to RS before news. The only way that this would be advantageous for NWBO would be to have it go into effect the very day or within a few days of brilliant TLD. There are better ways to effect a NASDAQ uplist.
RS before news is so extremely unlikely as that the possibility can be discounted to Zero. News is imminent and there is no benefit to anyone inside the company or shareholders to do a reverse split prior to news. The only benefit would be to shotsellers by decreasing their margin requirements to Short the stock of NWBO. Margin to short is currently $2.50 per share.
A knock out blow in the area of Cancer specifically in Glioblastoma and next in all solid tumors might come from the direction of
NorthWest. Biobuddy!
CytoDyn is breaking out to the upside again today and this week. Doubters and shorterss can breakout their rage pillows and scream scam into it. That will have about the same effect as continuing to screech SCAM onto this message board. Sorry shorters you will be burned. Doubters will be left behind of possibly one of the best investing ideas of this generation.
I can not think of a much more foolhardy investment choice than buying call options on a Pre revenue biotech. SMH! Except shorting a pre Revenue biotech with a beaten down price headed to a binary event that could 5x or 10 x the share price on interim trial readout. That is the riskiest of all with an unlimited loss potential.
CytoDyn is owned mostly by relatively wealthy investors who do not trade. The traders are the short sellers. There are a few traders sure as in any stock it is just a ticker to them. Real investors seek wealth by long term buy and holds and shun any taxable short term gains through trading. They buy dividend paying stocks and other investments for income as tax treatment is better. This is the United States where most of the CYDY stock is held. Tax treatments of trading might not be as onerous in your Country so you might not understand.